Phytopharm strikes deal for Chinese memory program
Phytopharm has struck a licensing deal with The Beijing Institute for its lead program for memory and concentration. The institute has a library of compounds based on traditional Chinese medicine. No financial terms were released.
- read the report from Hemscott
Related Articles:
Animal rights attack prompts Phytopharm biotech broker to resign. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
